Evidence is presented which supports the postulate that the photobilirubins IIA and IIB are diastereoisomers in which the C-3 vinyl group has cyclized intramolecularly. The evidence comes principally from proton n.m.r. spectroscopy at 400MHz and from chemical considerations. The cyclic structures require the E-configuration at the C-4 double bond in the precursor; this is the first structural evidence for the Z -iE isomerization in bilirubin and supports the view that the precursor (photobilirubin IA or IB) is (4E, 15Z)-bilirubin. Brief irradiation of photobilirubin II gives bilirubin, a new compound (photobilirubin III) and unchanged starting material. The various photoisomers are discussed in terms of their inter-relationships and biological fates.
Since its discovery by Cremer et al. (1958) the phototherapy of neonatal hyperbilirubinaemia has gained increasing acceptance in clinical medicine (Seligman, 1977) . The lowering of serum bilirubin concentrations appears to occur along at least two distinct pathways. The reported increase in propentdyopent adducts in the urine after phototherapy (Porto, 1970) suggests a photodegradation pathway. This has attracted considerable interest, as a result of which bilirubin is now known to be readily photo-oxidized in hydroxylic solvents to various water-soluble products, including propentdyopent adducts (Bonnett & Stewart, 1975) . There is much evidence which suggests that singlet oxygen is involved in this reaction (McDonagh, 1971 ; for review; see Lightner, 1977) .
A second mechanism, which is at present generally regarded as the major pathway, involves photosolubilization. Early physiological experiments on human infants (Lund & Jacobsen, 1972) and on Gunn rats (Ostrow, 1971) showed that irradiation of the animal led to the increase of bilirubin secretion in the bile. The light had solubilized the bilirubin (1), so that it could be excreted by the liver without hydrophilic conjugation. The cause of the insolubility of bilirubin was evident from X-ray crystal analysis, which established the 4Z,15Z structure (1) with a closelyknit system of six hydrogen bonds - . Clearly, a photoisomerization at the C-4-C-5 * To whom reprint requests should be sent. Vol. 201 and/or C-15-C-16 bond would generate a system (e.g. structure 2) in which the hydrogen bonding propensities of the various polar groups could no longer be satisfied intramolecularly and the molecule would be expected to hydrogen-bond to molecules of solvent water, and thus to become more soluble in that solvent (Bonnett, 1976; McDonagh & Palma, 1977; Bonnett et al., 1978) . This idea required as a basis the secure knowledge, which the X-ray work afforded, of the configuration of ordinary bilirubin.
Evidence for a photoequilibrium with small amounts of photobilirubins which are more soluble in aqueous media, and which revert, more or less readily, to bilirubin, has come from irradiation of bilirubin solutions, preferably in the absence of oxygen. Three research groups have been active, and have used different nomenclatures for the photobilirubins. Although reasonable doubt has been expressed about the identity of the various photoproducts (McDonagh et al., 1980) the relationship between the photoproducts is probably as shown in Table 1 .
The major photoproduct (EZ/ZE, peak 3, photobilirubin IA/IB) is probably a mixture of (4E,15Z)-bilirubin (2) and (4Z,15E)-bilirubin, as proposed by ), Lightner et al. (1979a (2) serum of jaundiced infants (Onishi et al., 1979 (Onishi et al., , 1980a and of Gunn rats (McDonagh et al., 1980) undergoing irradiation.
Another photoproduct (peak 2, 'unknown pigment', photobilirubin IIA/IIB) has been detected in the bile of irradiated jaundiced infants (Onishi et al., 1980a) and of irradiated Gunn rats (Ostrow et al., 1974; Zenone et al., 1977; Stoll et al., 1981) . It is rapidly excreted in bile when injected into Gunn rats Stoll et al., 1981) . Here it will be referred to as photobilirubin II. Its structure is unknown, and is the subject of the present paper. The aqueous phase was extracted with chloroform (4 x-50 ml). The combined chloroform solution was washed with water (3 x 1 litre), each washing being back-extracted with chloroform (2 x 50 ml) to minimize loss of pigment. Each chloroform washing was recombined with the main chloroform solution. The resulting chloroform solution was filtered through a chloroform-moistened cottonwool plug and taken to dryness under reduced pressure at <400C. The residue, containing mainly bilirubin with some photobilirubins, was leached with methanol (3 x 10ml). The methanol extracts were decanted from the insoluble bilirubin, filtered through methanol-moistened cottonwool (previously washed with methanol) and evaporated to dryness. The residue was again treated with methanol (2 x 10ml). If at this stage there was an appreciable residue, the procedure was repeated using methanol (2 x 5 ml). The insoluble residue from the methanol extractions is bilirubin of adequate purity for re-use in this preparation. The final methanol extract was taken to dryness under reduced pressure and applied in chloroform to a thin-layer plate and developed with chloroform/ methanol/water (40:9: 1, by vol.). Photobilirubin II appeared as a major yellow band at RF about 0.41. A minor band just resolved from and below this band is regarded as the XIIIa isomer of photobiliburin II; the proportion of this material increased as the bilirubin was recycled. The evidence for the identity of this lower band was that it gave bilirubin XIIIa on irradiation. The major bands of high RF were bilirubin (RF about 0.87) and photobilirubins IA (RF about 0.80) and IB (RF about 0.65).
Experimental
Photobilirubin II was eluted from the silica with the development solvent slightly enriched in methanol, and the solution was evaporated under reduced pressure at <401C. To remove traces of water the residue was dissolved in acetone, and again taken to dryness as before. Such a procedure typically gave about 2mg (1%) of photobilirubin II as an amorphous yellow-brown solid.
Photobilirubins IIA and IIB As reported previously (Stoll et al., 1979 6A(max.) = 400000M -cm-'). On repeating the t.l.c., photobilirubin III was converted mainly into photobiliburin II.
Results and discussion
The spectrum of bilirubin has been recorded previously at lower field and the chemical-shift assignments are given in Fig. 1 . Expanded portions of the 1H n.m.r. spectra of bilirubin and photobilirubin II are shown in Figs. 2, 3, 4 and 5.
The spectrum of photobilirubin II shows a number of high-field signals, some of which are interpreted as impurities. The sample of photobilirubin II examined is a mixture of two components (IIA/IIB, separable by analytical t.l.c., but so far resistant to purification by preparative-scale t.l.c.). Moreover the manner of preparation of photobilirubin II, which involves purification by differential extraction and not by crystallization, is more likely to be associated with the presence of minor contaminants. Initial spectra taken at lower field could not be interpreted, but the spectrum at 400 MHz permits structural conclusions.
The key differences between the two spectra are as follows.
(a) Olefinic protons (Fig. 2) The olefinic region of the spectrum of bilirubin shows an ABX system attributed to the vinyl group at C-3, and an AMX system attributed to the vinyl group at C-18, together with a singlet for the two meso protons. A comparison with this region in photobilirubin II (Table 2 ) reveals that one vinyl group has changed and that, provided the original assignments in Fig. 1 are correct, then the vinyl group at C-3 is the one that is affected. It is also evident that one meso proton (66.1 1 p.p.m.) has been altered in some way, and that two new olefinic protons (65.78 and 5.89) are revealed.
(b) C-JO protons (Fig. 3) The protons of the C-10 methylene group are (Fig. 5 ) The spectrum of bilirubin shows no signals in this region, apart from an unassigned peak attributed to an impurity at approx. 51.15, which is also found in the spectrum of photobilirubin II. The latter shows a set of signals (Fig. 5) , which are crucial to the present interpretation, and which represent methyl groups in saturated environments. This region sometimes reveals impurities in samples prepared by evaporation, but in the present study these peaks, and their relative areas, were reproducible from one preparation to another, whereas the signals attributed to impurities were variable. This is illustrated in Fig. 5 , since the expanded spectrum was from a sample different from that which gave the non-expanded spectrum. The signal at 31.15 has a different intensity relative to the remaining signals in the two spectra. Proposed structurefor photobilirubin II The n.m.r. results indicate that the C-3 vinyl group disappears when photobilirubin II is formed. The possibility that solvent has added to the vinyl group has been considered, since this is a known reaction (Manitto, 1971; Manitto & Monti, 1974) . However, the product would be expected to give a normal diazo reaction, which photobilirubin II does not (Stoll et al., 1979) . Moreover there is some evidence that photobilirubin II is isomeric with bilirubin (Stoll et al., 1979) . Attempts to crystallize photobilirubin II have so far proved unsuccessful. Elemental analysis on the amorphous material shows that it contains no sulphur, so that dimethyl sulphoxide has not added to the molecule. This is further supported by our isolation of photobilirubin II after irradiation of bilirubin in 8M-urea and in chloroform. An isomeric structure is suggested by the mass-spectral observations on photobilirubin II and its dimethyl ester (Stoll et al., 1979) and by the photochemical reversion of photobilirubin II into bilirubin.
If photobilirubin II is an isomer of bilirubin, then the only way that the vinyl group at C-3 can disappear with overall loss of olefinic protons (8 -6, Table 2 ) is by an intramolecular cycloaddition reaction. Several possible modes of cyclization are considered in Fig. 6 ; no attempt is being made to present conformation or hydrogen bonding. The commentary in Fig. 6 argues against structures (7), (8) and (9).
Structures (3), (4), (5) and (6) represent the products of alternative pathways for cyclization between C-32 and ring B; in each case the C-4-C-5 bond must have E-configuration. The examination of models does not convincingly indicate a preference for any one of these cyclizations. However, the 1H n.m.r. spectrum clearly favours (3) or (6), since these are the only structures that have two methyl groups attached to saturated centres, one of the type Me-C-and one of the type Me-C-H.
Moreover, the former 3-vinyl group, now present as a =CH-CH2-unit in all four structures (3-6), is detected in the n.m.r. spectrum by double-resonance experiments. The multiplet at 35.89, assigned to the olefinic component of this unit, became two unequal singlets on irradiation at 32.5. Conversely irradiation at 35.89 caused modification in the 32.5 region; this region is less easy to interpret because it is partly obscured by a f3-methylene resonance of the propionic acid side chains, but there was clear evidence for the collapse of two doublets at 32.64 and 2.60 to singlets (Fig. 7) . This chemical shift, 32.6, would be appropriate for structures (3), (5) (Bois-Choussy & Barbier, 1977) .
The following evidence accords with either of the working proposals (3) (Stoll et al., 1979) .
(v)
The photocyclization is reversible; this might be explained by electrocyclic reactions of the types
We know at present of no exact analogies for these postulated reactions, which require an initial tautomerization in the A/B pyrromethenone system. The forward reaction to structure (3) has some parallel in the photocyclization of phorcabilin to sarpedobilin (Bois-Choussy & Barbier, 1977) . The route to structure (6) requires lactonization by conjugate addition to an a,,-unsaturated azomethine. Because the C-8 hydrogen in structure (6) is acidic, this addition would be expected to be readily reversible.
Only one piece of evidence from the n.m.r. spectrum appears not to support structures (3) and (6); this is in the NH/OH region, where the signals are broader than they are in bilirubin, and where they integrate to only 3-4 protons. However, since such signals are susceptible to broadening and to change of chemical shift we prefer to place more reliance on the preponderance of evidence from signals due to carbon-bound protons.
The i.r. spectrum should clearly differentiate structures (3) and (6) and indeed the published spectrum (Stoll et al., 1979) shows a sharp peak at 1740cm-', which might be attributed to a 6-lactone. Moreover, structure (6), with an electron-withdrawing group (C=N) substituted at C-10, would account well for the failure of photobilirubin II to give a normal diazo reaction (Stoll et al., 1979) . However, our present measurements of the i.r. spectrum of photobilirubin II do not reveal a clear peak at 1740cm-1, although there is extra ab-. sorption in this region. On balance we prefer at this preliminary stage to leave the choice between structures (3) and (6) an open question. Initial attempts to measure '3C n.m.r. spectra of photobilirubin II have been unsuccessful due to its instability.
However, on the evidence presented here the intramolecular cyclization of the 3-vinyl group is clear. The product and its precursor must for steric reasons have the 4E-configuration. This constitutes the first structural evidence for the occurrence of a Z-*E change at a bridge double bond on irradiation of bilirubin. Thus it is postulated that photobilirubins IA/IB are (4E, 1 5Z)-bilirubin and (4Z, 15E)-bilirubin, the former of which gives rise to the diastereoisomeric photobilirubins IIA and IIB possessing the cyclo-4E,1 5Z-configuration. This view is supported by the formation of a new photobilirubin, photobilirubin III, on irradiating photobilirubin II. Photobilirubin III appears to bear the same structural relationship to photobilirubin II as photobilirubin I bears to bilirubin. Photobilirubin III presumably has the cyclo-4E, 15E-configuration. The proposed relationships between the photoproducts, including those not yet detected but which would be expected to occur in low concentrations in photoreaction mixtures, are given in Fig. 8 .
Physiological significance ofthe photobilirubins
Recent work has indicated that photobilirubin I reaches a significant concentration in serum during neonatal phototherapy (Onishi et al., 1980a) , but is excreted by the liver without conjugation and reverts spontaneously to bilirubin in the bile. Photobilirubin II is excreted more efficiently so that it is not detected in the serum during phototherapy but is found in relatively high concentration in the bile (Onishi et al., 1980a) . The roles of photobilirubin III and (4E,15E)-bilirubin IXa in phototherapy have not been demonstrated but they may be important as rapidly excreted substances, never reaching significant concentrations in the serum, but reverting in the bile to photobilirubin II and bilirubin respectively and contributing significantly to the overall bilirubin turnover.
